恶性胸膜间皮瘤的容积评估
Volumetric assessment in malignant pleural mesothelioma.
作者信息
Murphy David J, Gill Ritu R
机构信息
Division of Thoracic Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
出版信息
Ann Transl Med. 2017 Jun;5(11):241. doi: 10.21037/atm.2017.05.23.
Abstract
Malignant pleural mesothelioma (MPM) is a highly malignant pleural neoplasm with a dismal prognosis. Multimodality approach including surgery and chemotherapy are utilized to treat patients with resectable disease. Clinical staging allows for selection of patients for treatment strategies, but has not been found to be prognostic and is plagued by high interobserver variability. Tumor volume measurement on cross-sectional imaging has emerged as a potential quantitative tool with prognostic significance. This review focuses on volumetric assessment from cross-sectional imaging (CT, MRI, F-FDG PET/CT) and the potential prognostic benefit and applications.
摘要
恶性胸膜间皮瘤（MPM）是一种预后极差的高度恶性胸膜肿瘤。包括手术和化疗在内的多模式方法用于治疗可切除疾病的患者。临床分期有助于选择治疗策略的患者，但尚未发现其具有预后价值，且存在较高的观察者间变异性。横断面成像上的肿瘤体积测量已成为一种具有预后意义的潜在定量工具。本综述重点关注横断面成像（CT、MRI、F-FDG PET/CT）的容积评估以及潜在的预后益处和应用。
相似文献
1
Volumetric assessment in malignant pleural mesothelioma.恶性胸膜间皮瘤的容积评估
Ann Transl Med. 2017 Jun;5(11):241. doi: 10.21037/atm.2017.05.23.
2
Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?正电子发射断层扫描能否为恶性胸膜间皮瘤提供预后信息？
Interact Cardiovasc Thorac Surg. 2011 May;12(5):806-11. doi: 10.1510/icvts.2010.255901. Epub 2011 Jan 25.
3
Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描延迟相在恶性胸膜间皮瘤的诊断和预后中的临床意义。
Oncol Rep. 2012 Feb;27(2):333-8. doi: 10.3892/or.2011.1520. Epub 2011 Oct 24.
4
Morphologic and functional imaging of malignant pleural mesothelioma.恶性胸膜间皮瘤的形态学和功能成像
Eur J Radiol. 2007 Dec;64(3):356-66. doi: 10.1016/j.ejrad.2007.08.010. Epub 2007 Oct 22.
5
What is the best way to diagnose and stage malignant pleural mesothelioma?诊断和分期恶性胸膜间皮瘤的最佳方法是什么？
Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):254-9. doi: 10.1510/icvts.2010.255893. Epub 2010 Nov 1.
6
7
Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.继续培美曲塞和铂类化疗治疗恶性胸膜间皮瘤（MPM）：18F-FDG-PET/CT 的价值。
Eur J Radiol. 2012 Jan;81(1):e19-25. doi: 10.1016/j.ejrad.2010.11.006. Epub 2010 Dec 3.
8
Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.恶性胸膜间皮瘤表现为腰痛：通过骨扫描与 F-18 FDG PET/CT 协调诊断。
Spine (Phila Pa 1976). 2009 Oct 1;34(21):E780-3. doi: 10.1097/BRS.0b013e3181ae8294.
9
Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.计算机断层扫描、正电子发射断层扫描、正电子发射断层扫描/计算机断层扫描以及磁共振成像用于局限性胸膜间皮瘤分期：初步结果
Invest Radiol. 2008 Oct;43(10):737-44. doi: 10.1097/RLI.0b013e3181817b3d.
10
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.18F-FDG标准摄取值通过PET/CT融合显像在恶性胸膜间皮瘤分期中的预后价值
Technol Cancer Res Treat. 2012 Apr;11(2):163-7. doi: 10.7785/tcrt.2012.500245.
引用本文的文献
1
Convolutional Neural Networks for Segmentation of Pleural Mesothelioma: Analysis of Probability Map Thresholds (CALGB 30901, Alliance).用于胸膜间皮瘤分割的卷积神经网络：概率图阈值分析（CALGB 30901，联盟）
J Imaging Inform Med. 2025 Apr;38(2):967-978. doi: 10.1007/s10278-024-01092-z. Epub 2024 Sep 12.
2
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目：即将发布的第九版胸膜间皮瘤 TNM 分类中“T”描述符修订建议。
J Thorac Oncol. 2024 Sep;19(9):1310-1325. doi: 10.1016/j.jtho.2024.03.007. Epub 2024 Mar 21.
3
4
Deep learning for diagnosis of malign pleural effusion on computed tomography images.基于 CT 图像的深度学习在恶性胸腔积液诊断中的应用
Clinics (Sao Paulo). 2023 May 5;78:100210. doi: 10.1016/j.clinsp.2023.100210. eCollection 2023.
5
Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma.肌肉减少症、心前区脂肪组织和高肿瘤体积作为手术治疗胸膜间皮瘤的预后预测因素
Diagnostics (Basel). 2022 Jan 3;12(1):99. doi: 10.3390/diagnostics12010099.
6
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.评估血清可溶性间皮素相关肽（SMRP）作为胸膜间皮瘤（PM）临床监测标志物的初步研究：与改良RECIST评分的相关性
Diagnostics (Basel). 2021 Oct 29;11(11):2015. doi: 10.3390/diagnostics11112015.
7
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.将 CT 肿瘤体积和 CT 胸膜厚度纳入恶性胸膜间皮瘤的未来分期系统中。
Cancer Imaging. 2021 Aug 3;21(1):48. doi: 10.1186/s40644-021-00415-5.
8
Staging in the era of international databases: documented improvements with remaining challenges.国际数据库时代的分期：已证实的进展与尚存的挑战
J Thorac Dis. 2018 Feb;10(2):682-687. doi: 10.21037/jtd.2018.01.23.
9
Progress in the Management of Malignant Pleural Mesothelioma in 2017.2017 年恶性胸膜间皮瘤治疗进展。
J Thorac Oncol. 2018 May;13(5):606-623. doi: 10.1016/j.jtho.2018.02.021. Epub 2018 Mar 8.
本文引用的文献
1
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.IASLC 间皮瘤分期项目：对即将发布的第八版胸膜间皮瘤 TNM 分类中 T 描述符的修订建议。
J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147. Epub 2016 Sep 26.
2
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.一项关于容积计算机断层扫描用于恶性胸膜间皮瘤分期的多中心研究。
Ann Thorac Surg. 2016 Oct;102(4):1059-66. doi: 10.1016/j.athoracsur.2016.06.069. Epub 2016 Sep 2.
3
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.北美多中心容积CT用于恶性胸膜间皮瘤临床分期的研究：开展定量成像研究的可行性与组织安排
J Thorac Oncol. 2016 Aug;11(8):1335-1344. doi: 10.1016/j.jtho.2016.04.027. Epub 2016 May 12.
4
A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment.恶性胸膜间皮瘤反应评估的多模态成像综述
PET Clin. 2011 Jul;6(3):299-311. doi: 10.1016/j.cpet.2011.04.002.
5
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.恶性胸膜间皮瘤诊断与分期的多模态成像综述
PET Clin. 2011 Jul;6(3):275-97. doi: 10.1016/j.cpet.2011.04.001. Epub 2011 Jun 14.
6
Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.标本重量和体积：恶性胸膜间皮瘤生存的重要预测因素。
Eur J Cardiothorac Surg. 2016 Jun;49(6):1642-7. doi: 10.1093/ejcts/ezv422. Epub 2016 Jan 21.
7
Do Radiologists Have Stage Fright? Tumor Staging and How We Can Add Value to the Care of Patients with Cancer.放射科医生会怯场吗？肿瘤分期以及我们如何为癌症患者的护理增添价值。
Radiology. 2016 Jan;278(1):11-2. doi: 10.1148/radiol.2015151563.
8
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.肺容积测量作为恶性胸膜间皮瘤患者反应的替代标志物。
J Thorac Oncol. 2013 Apr;8(4):478-86. doi: 10.1097/JTO.0b013e31828354c8.
9
Initial analysis of the international association for the study of lung cancer mesothelioma database.国际肺癌研究协会间皮瘤数据库的初步分析。
J Thorac Oncol. 2012 Nov;7(11):1631-9. doi: 10.1097/JTO.0b013e31826915f1.
10
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.恶性胸膜疾病：扩散加权和动态对比增强磁共振成像的诊断——初步经验。
Radiology. 2012 Jun;263(3):884-92. doi: 10.1148/radiol.12110872. Epub 2012 Apr 24.
Zotero 插件